Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
16.53
-0.58 (-3.39%)
Nov 1, 2024, 4:00 PM EDT - Market closed
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anika Therapeutics stock have an average target of 24.5, with a low estimate of 24 and a high estimate of 25. The average target predicts an increase of 48.22% from the current stock price of 16.53.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ANIK stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barrington Research | Barrington Research | Buy Maintains $37 → $25 | Buy | Maintains | $37 → $25 | +51.24% | Nov 1, 2024 |
Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +123.84% | Oct 22, 2024 |
Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +123.84% | Aug 9, 2024 |
Stephens & Co. | Stephens & Co. | Hold Reiterates $24 | Hold | Reiterates | $24 | +45.19% | May 29, 2024 |
Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +123.84% | May 9, 2024 |
Financial Forecast
Revenue This Year
173.63M
from 166.66M
Increased by 4.18%
Revenue Next Year
182.29M
from 173.63M
Increased by 4.99%
EPS This Year
-0.21
from -5.64
EPS Next Year
0.23
from -0.21
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 178.9M | 188.4M | 205.8M | ||
Avg | 173.6M | 182.3M | 197.4M | ||
Low | 166.6M | 174.4M | 187.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.4% | 8.5% | 12.9% | ||
Avg | 4.2% | 5.0% | 8.3% | ||
Low | -0.0% | 0.5% | 2.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.07 | 0.44 | 0.95 | ||
Avg | -0.21 | 0.23 | 0.73 | ||
Low | -0.34 | -0.03 | 0.53 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 302.8% | ||
Avg | - | - | 211.6% | ||
Low | - | - | 125.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.